Epidemiology: Osteopenia and Osteoporosis – On the rise as the aging population grows

Introduction

The prevalence of hip fractures, a condition related to osteopenia and osteoporosis, increased during the latter half of the 20th century but has since leveled off or decreased in most markets. The current combined prevalence of osteopenia and osteoporosis is estimated at approximately 55% among people aged 50 and older and the total number of cases is expected to grow over the next decade.

Introduction

Gain insight to market potential, including a robust 10-year epidemiology forecast of osteopenia and osteoporosis total prevalent cases.
Understand the key epidemiologic risk factors associated with osteopenia, osteoporosis, and severe osteoporosis.

Highlights

During 2010, Datamonitor estimates that 117.9, 15.0, and 4.3 million total prevalent cases of osteopenia, osteoporosis, and severe osteoporosis, respectively, existed in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK).

Between 2010 and 2020, Datamonitor forecasts osteopenia, osteoporosis, and severe osteoporosis total prevalent cases in the seven major markets to increase by 14%, 17%, and 24%, resulting in 134.8 million, 17.5 million, and 5.3 million total prevalent cases in 2020, respectively.

Datamonitor estimates that in 2010, most total prevalent osteopenia, osteoporosis, and severe osteoporosis cases were in women (71.8 million or 61% of all cases; 12.4 million or 82% of all cases, and 3.75 million or 88% of all cases, respectively).


Highlights

What are the most robust sources for osteopenia and osteoporosis prevalence data?
How will the patient population change over the next decade in the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK)?
How do changes in population structure and risk factors affect the trend in prevalent osteopenia and osteoporosis cases?